COSMOS Pharmaceutical Corporation
3349.T · JPX
8/31/2025 | 5/31/2025 | 2/28/2025 | 11/30/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | ¥49,538,000 | ¥57,038,000 | ¥22,765,000 | ¥39,129,000 |
| Short-Term Investments | ¥0 | ¥0 | ¥0 | ¥0 |
| Receivables | ¥770,000 | ¥12,240,000 | ¥672,000 | ¥683,000 |
| Inventory | ¥89,165,000 | ¥92,323,000 | ¥88,059,000 | ¥93,850,000 |
| Other Curr. Assets | ¥19,746,000 | ¥1,164,000 | ¥15,367,000 | ¥16,358,000 |
| Total Curr. Assets | ¥159,219,000 | ¥165,622,000 | ¥126,863,000 | ¥150,020,000 |
| Property Plant & Equip (Net) | ¥336,842,000 | ¥331,125,000 | ¥320,043,000 | ¥309,706,000 |
| Goodwill | ¥0 | ¥0 | ¥0 | ¥0 |
| Intangibles | ¥670,000 | ¥446,000 | ¥431,000 | ¥453,000 |
| Long-Term Investments | ¥4,397,000 | ¥4,464,000 | ¥4,428,000 | ¥26,391,000 |
| Tax Assets | ¥0 | ¥2,913,000 | ¥0 | ¥0 |
| Other NC Assets | ¥23,177,000 | ¥20,185,000 | ¥22,336,000 | ¥1,000 |
| Total NC Assets | ¥365,086,000 | ¥359,133,000 | ¥347,238,000 | ¥336,551,000 |
| Other Assets | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Assets | ¥524,305,000 | ¥524,755,000 | ¥474,101,000 | ¥486,571,000 |
| Liabilities | – | – | – | – |
| Payables | ¥178,973,000 | ¥177,125,000 | ¥156,818,000 | ¥173,939,000 |
| Short-Term Debt | ¥5,482,000 | ¥5,682,000 | ¥8,006,000 | ¥4,331,000 |
| Tax Payable | ¥0 | ¥0 | ¥0 | ¥0 |
| Deferred Revenue | ¥0 | ¥380,000 | ¥0 | ¥0 |
| Other Curr. Liab. | ¥27,184,000 | ¥27,177,000 | ¥24,163,000 | ¥34,563,000 |
| Total Curr. Liab. | ¥216,036,000 | ¥220,680,000 | ¥195,664,000 | ¥212,833,000 |
| LT Debt | ¥36,064,000 | ¥37,202,000 | ¥20,523,000 | ¥21,344,000 |
| Deferred Rev, NC | ¥0 | ¥0 | ¥0 | ¥0 |
| Deferred Tax Liab, NC | ¥0 | ¥0 | ¥0 | ¥0 |
| Other NC Liab. | ¥9,545,000 | ¥4,591,000 | ¥9,089,000 | ¥8,909,000 |
| Total NC Liab. | ¥45,609,000 | ¥46,610,000 | ¥29,612,000 | ¥30,253,000 |
| Other Liabilities | ¥0 | ¥0 | ¥0 | ¥0 |
| Cap. Leases | ¥0 | ¥7,073,000 | ¥0 | ¥0 |
| Total Liabilities | ¥261,645,000 | ¥267,290,000 | ¥225,276,000 | ¥243,086,000 |
| Equity | – | – | – | – |
| Pref Stock | ¥0 | ¥0 | ¥0 | ¥0 |
| Common Stock | ¥4,178,000 | ¥4,178,000 | ¥4,178,000 | ¥4,178,000 |
| Retained Earnings | ¥253,508,000 | ¥248,309,000 | ¥239,674,000 | ¥234,335,000 |
| AOCI | ¥96,000 | ¥100,000 | ¥94,000 | ¥97,000 |
| Other Equity | ¥2,000 | ¥2,000 | ¥2,000 | ¥1,000 |
| Total Equity | ¥262,658,000 | ¥257,463,000 | ¥248,822,000 | ¥243,485,000 |
| Supplemental Information | – | – | – | – |
| Minority Interest | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Liab. & Tot. Equity | ¥524,303,000 | ¥524,755,000 | ¥474,098,000 | ¥486,571,000 |
| Net Debt | -¥7,992,000 | -¥14,154,000 | ¥5,764,000 | -¥13,454,000 |